Partner Event:
China Healthcare Summit
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.


Written by Richard Daverman, PhD.

Click a link below to view the mailing archive as if it had been sent to you.

2013-01-30 01:30Lee's Pharma Gains Negotiation Option for China Rights to Anticoagulant
2013-01-29 01:30Aoxing Pharma Receives License for Narcotic Cough Treatment
2013-01-27 01:30Week in Review: 2012 China Life Science VC, M&A, and Partnering Climb
2013-01-26 01:30Huapont Pharma and Yes Biotech to Partner on Psoriasis Ointment and more...
2013-01-25 01:30Wilex Selects GeneDiagnostics to Distribute Cancer Test in China
2013-01-24 01:30Simcere Sells Celgen Stake for $49 Million
2013-01-23 01:30Hisun In-Licenses China Rights to Celsion's Cancer Drug for $100 Million and more...
2013-01-22 01:30VC Investment, M&A and Cross-border Partnerships Boom in China Life Science and more...
2013-01-20 01:30Week in Review: Stryker Pays $764 Million for China Orthopedic Maker
2013-01-19 01:30China Proposes Fast-Track Approvals for Innovative Drugs and more...
2013-01-18 01:30Stryker Buys Trauson, a China Orthopedic Company, for $764 Million
2013-01-17 01:30Sanjiu Medical Pays $94 Million for China Medical Patch Maker and more...
2013-01-16 01:30Nanjing Micro-Tech Announces "Significant" Investment from Actis
2013-01-15 01:30China National Biotec's $1.5 Billion IPO is Rumored Again and more...
2013-01-13 01:30Week in Review: China's Joinn Labs Buys Major Biopharma Campus in San Francisco
2013-01-12 01:30Zhifei Biological Approved to Begin Phase III Trial of TB Vaccine
2013-01-11 01:30China View: JP Morgan Healthcare Conference, 2013 and more...
2013-01-10 01:30Guangdong Dahuanong Animal Health Buys Majority Stake in Competitor
2013-01-09 01:30Joinn Labs of China Buys Bayer's San Francisco-Area Campus and more...
2013-01-08 01:30Shanghai Fosun Pharma Buys Majority of Hunan Dongting for $93 Million and more...
2013-01-06 01:30Week in Review: Cellular Biomedicine of China to Reverse Merger in US
2013-01-05 01:30China's Cellular Biomedicine Group Announces Reverse Merger
2013-01-04 01:30China's BeBetter Medicine and PharmaEngine of Taiwan Form Cancer JV
2013-01-03 01:30Tianjin KingYork and Innovata Announce $190 Million Asthma JV
2013-01-01 01:30Sichuan Kelun Pharma Buys 12% of Lijun Pharma for $135 Million

 

<< Archive IndexSubscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC